background

32
ESTROGEN AND ANTI-ANDROGEN INDUCED PENILE MAL- DEVELOPMENT LILIAN OKUMU TUSKEGEE UNIVERSITY, TUSKEGEE, AL, USA

Upload: shoshana-benjamin

Post on 31-Dec-2015

21 views

Category:

Documents


1 download

DESCRIPTION

Estrogen and anti-androgen Induced Penile Mal-development Lilian Okumu Tuskegee University, Tuskegee, AL, USA. Background. Endocrine disrupting chemicals interfere hormonal balance; present in the environment e.g. in cosmetics, medical instruments and agriculture. Background. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Background

ESTROGEN AND ANTI-ANDROGEN INDUCED PENILE MAL-DEVELOPMENT

LILIAN OKUMU

TUSKEGEE UNIVERSITY, TUSKEGEE, AL, USA

Page 2: Background

Background

• Endocrine disrupting chemicals interfere

hormonal balance; present in the

environment e.g. in cosmetics, medical

instruments and agriculture

Page 3: Background

•Synthetic: diethylstilbestrol (DES), Ethinyl estradiol (EE)

•Phytoestrogens: Plant origin isoflavones (genistein, daidzen)

•Environmental: Bisphenol A (BPA), Methoxychlor (MXC), Pthalates

Background

Page 4: Background

Background

•DES daughters have higher incidence of vaginal cancer; sons: testicular cancer and hypospadias

•BPA causes prostate hypertrophy and precancerous growth

•MXC causes lower fertility in females

•EE: More than two million women continue to take contraceptive pills during the first trimester of pregnancy

Page 5: Background

Background: effects on wildlife

•Alligators from Lake Apopka (FL) contaminated with industrial estrogenic contaminants have smaller phallus and reduced fertility.

•Turtles from Mody Pond (MA) contaminated with xenobiotics have impaired reproductive functions.

•Fish from some rivers in the USA and Europe contaminated with oral contraceptives are feminized.

Page 6: Background

Summary of background

•It is well-established that perinatal exposure to estrogenic compounds (endocrine disruptors) has permanent deleterious effect on the development of reproductive organs in both humans and wildlife.

•However, mechanisms underlying these reproductive disorders are not well-understood.

Page 7: Background

•Chemicals: DES (diethylstilbestrol), estradiol valerate (EV),

or ethinyl estradiol (EE). All three compounds caused similar

mal-developments

•Animals: Neonatal rats and mice

•Treatment: 10ng-10µg/day/pup, 1-6 postnatal days, sc

•Tissue collection: Ages at day 7, 12, 18, 28, 41, or adulthood. •Analyses: hormone assays, gene expression (micro array and Q-RT-PCR), WB

Experimental design

Page 8: Background

Study-1: Estrogen-induced mal-development of the penis

Goyal et al. (2004) Reproductive Toxicology 18:265-274

Page 9: Background

Study-1: Estrogen-induced accumulation of fat cells and loss of smooth muscle cells

Control DES

Goyal et al. (2004) Reproductive Toxicology 18:265-274

Page 10: Background

Study-1: Estrogen-induced accumulation of fat cells occurs in the corpora cavernosa, but not in the

corpus spongiosus

Corpus Spongiosus

Corpora Cavernosa

Goyal et al. (2004) Biology of Reproduction 18:265-274

Page 11: Background

Study-2: Estrogen-induced penile mal-development is dose-dependent:

Neonatal Exposure to ethinyl estradiol (EE), female

contraceptive, at a dose of 100 ng (0.01 mg/kg) or

higher results in infertility and malformation of penis

in 100% of the treated rats

Mathews et al. (2009) Toxicological Sciences 112:331-343, Okumu et al, in preparation

Page 12: Background

Study-2: Radiographs of the penis treated with different doses of EE

Mathews et al. (2009) Toxicological Sciences 112:331-343

Ethinyl Estradiol

Page 13: Background

Study-3: Estrogen-induced penile mal-development is dependent upon estrogen exposure during critical

period of development

Goyal et al. (2005) Toxicological Sciences 87:242-254

Page 14: Background

Study-4: Estrogen-induced penile mal-development is associated with lower intra-testicular T Surge (typical for rodents from gestation day 17 to postnatal days

7-10)

Goyal et al. (2009) Biology of Reproduction 81:242-254

ng/g

0

500

1000

1500

20004-Day -Old 5-Day -Old 6-Day -Old

Testicular Testosteroneng

/g

0

200

400

600

ng/t

esti

s

0

3

6

7-Day-Old

Fig. 1; Goyal et al.

A

B

C

**** *

7-Day-Old

* * *

* * * * *

(5)

(14)

(8)

(14)

(11)

(20)

(14)

(8)

(14)

(15) (7)

(8)

(8) (8)

Page 15: Background

Control DES

Study-5: Estrogen-induced penile mal-development is associated with ERα up-

regulation

Goyal et al (2004) Biology of Reproduction 70:284-297Goyal et al (2007) Reproduction 134:199-208

Page 16: Background

Study-6: ERα presence is essential for estrogen-induced penile mal-development

Goyal et al (2007) Reproduction 133:1057-1067

ERKO Data

Pen

is W

eigh

t (g)

0.00

0.01

0.02

0.03

0.04

0.05

Pen

is L

engt

h (m

m)

4

8

12

16

WC WD KC KD

*

*

WC WD KC KD

Page 17: Background

Study-7: Estrogen-induced penile mal-development is mitigated by ER antagonist ICI 182780 and AR agonist DHT or testosterone

(T)

Goyal et al. (2009) Biology Reproduction 81:242-254

Page 18: Background

Studies-9&10: Estrogen induced penile mal-development is characterized by down-regulation of smooth muscle cell

markers in the penis and steroidogenic enzymes in the testis

Okumu et al., 2012

Page 19: Background

Study-9: similar to estrogen, GnRH antagonist antide (GnRH-A) supressed intratesticular testosterone surge and mRNA for

steroidogenic enzymes

Okumu et al., 2014

Page 20: Background

Fo

ld c

han

ge

in g

ene

exp

ress

ion

rel

ativ

e to

Co

ntr

ol

0

1

2

3

4

521-day-old

a aa

a a

b

a,b a,b

b b

a

a a

c

a

b

a

c6 6 5 5 6 4

PPARMyh11Esr1

Estrogen up-regulates Esr1 and Pparγ mRNA and down-regulates Myh11 mRNA and these alterations are Mitigated

by Estrogen Receptor Antagonist ICI and DHT

Okumu et al., 2012

Page 21: Background

Both estrogen and GnRH-A treatment induced similar effects in the penis

Ctrl DES

DES+DHT

DES+ICI DHT IC

I0

1

2

3

4

5

Rela

tive

fold

cha

nge

b

a,c

aa,c

a,c

a,c

Control Antide Ant + DHT Ant + ICI0

2

4

6

8

Rela

tive

fold

cha

nge

a

b

c

b,d

Page 22: Background

MYH11 protein expression in the penis

Control DES0

0.4

0.8

1.2

Ban

d d

en

sity

***

Page 23: Background

ACTA immunolocalization

Page 24: Background

Results: ACTA IHC

Control DES-treated

Page 25: Background

Down-regulation of the smooth muscle cell marker Myh11 was specific to the corpus cavernosum penis

10

2

4

6

8

10

12

14

16

18Q-RT-PCR: Myh11 expression

Control GnRH-A EE

RFC

in M

yh11 e

xpre

ssio

n

Corpus cavernosum Corpus spongiosum Prostate

*

***

Page 26: Background

Similarly, estrogen and anti-androgen induced effects on Pde5a were limited to the corpus cavernosum penis

10

1

2

3

4

5

6 Q-RT-PCR: Pde5a expression

Control GnRH-A EE

RFC

in P

de5a e

xpre

ssio

n

Corpus cavernosum Corpus spongiosum Prostate

** **

Page 27: Background

PDE5A protein is downregulated in GnRH-A treated penile tissues

Page 28: Background

Summary of results

Neonatal treatment with DES and antide…

Suppressed testicular testosterone surge at

day 7

Decreased MYH11, ACTA2 and PDE5A

expression

Increased PPARG & ESR1 expression

Both DHT and ICI mitigated DES-induced

effects in the penis

However, ICI unable to mitigate antide effects

Page 29: Background

Conclusions

Anti-androgens cause permanent mal-development

of the penis, similar to estrogenic exposure

Low androgen levels/action due to DES impedes

differentiation of stromal cells into smooth muscle

cells in the corpus cavernosum while enhancing

adipogenesis.

ESR1 mediated pathway and low T involved in DES;

low T in GnRH-A

Page 30: Background

E

Leydig Cell Stromal Cell Stromal Cell

Hypothesis for mechanism of estrogen-induced mal-development of the penis

Testosterone ERaPPARg,

MYH11, ACTA2

Page 31: Background

Acknowledgements

Dr. Hari Goyal Dr. Liz SimonDr. Tim BradenMs. Carol S. WilliamsMr. John W. WilliamsDr. Datiri & CMRC staff

Page 32: Background

THANK YOU